Flywheel, the leading cloud-based data management platform for biomedical research and collaboration, today announced the closure of its Series C funding round including an investment from Intuitive Ventures, a venture capital fund dedicated to advancing the future of minimally invasive care and beyond. This brings Flywheel’s Series C round to a total of $27.5 million.
“Flywheel is built to accelerate research collaboration, enable machine learning and streamline data management, and this investment is fuel for that work,” said Jim Olson, CEO of Flywheel. “We’re grateful for the financial support from Intuitive Ventures and are excited to continue developing tools like our upcoming discoverable network for data and algorithms that will help researchers access more real-world data and collaborate in new ways.”
Intuitive Ventures, the venture capital arm of Intuitive, the pioneer of robotic-assisted surgery, is focused on accelerating early-stage companies working to bring positive outcomes to patients, providers, hospitals and healthcare systems. Through its investment, Intuitive Ventures recognizes Flywheel’s ability to enable scalable infrastructure for collaboration and the advancement of AI technologies across biomedical and clinical fields.
“Flywheel is laying powerful foundations for the future of AI development and scientific collaboration between research settings, life sciences and, ultimately, clinical practice,” said Oliver Keown, MD, Director of Intuitive Ventures. “Flywheel’s tailored data management solutions, impressive network of users and the team’s depth in unlocking value from complex data position them for tremendous impact.”
Flywheel is the revolutionary research data management platform powering healthcare innovation by accelerating collaboration, enabling machine learning, and streamlining the massive task of data aggregation, curation and management. By leveraging cloud scalability and automating research workflows, Flywheel helps organizations scale research data and analysis, improve scientific collaboration and accelerate discoveries. Flywheel offers comprehensive solutions for life sciences, pharmaceutical, biotech, academic, and clinical research. Flywheel is headquartered in Minneapolis and has offices in the Bay Area, St. Louis, and Budapest. For more information on our mission and products, visit www.flywheel.io or follow us on Twitter and LinkedIn.
About Intuitive Ventures
Leveraging Intuitive’s entrepreneurial spirit and expansive technological and clinical reach, Intuitive Ventures invests in transformative opportunities advancing positive outcomes in healthcare. The fund is focused on US and international early-stage start-ups and takes a long-term outlook to support portfolio companies reach their major milestones. Through its inaugural $100 million fund and with leadership combining decades of investing and operational experience, the team cultivates strategic resources to drive financial returns and accelerate the future of minimally invasive care. More information and future updates can be found at: www.intuitive-ventures.com.